U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Low-Dose Aspirin Use for the Prevention of Morbidity and Mortality From Preeclampsia: Preventive Medication

About this resource:

Systematic Review

Source: U.S. Preventive Services Task Force

Last Reviewed: September 2014

Workgroups: Maternal, Infant, and Child Health Workgroup

The U.S. Preventive Services Task Force (USPSTF) recommends that women who are at a high risk for preeclampsia take a low dose of aspirin to reduce their risk of preeclampsia and the harm it causes. Specifically, USPSTF recommends that clinicians prescribe low-dose (81 mg per day) aspirin after 12 weeks of pregnancy to women with at least 1 of the following:

  • Had preeclampsia in a previous pregnancy
  • Are pregnant with more than one baby
  • Have chronic hypertension
  • Have type 1 or type 2 diabetes
  • Have kidney disease
  • Have certain autoimmune diseases
Read more about this resource

Objectives related to this resource (2)

Reduce maternal deaths — MICH‑04
LHI label
Getting worse
Reduce severe maternal complications identified during delivery hospitalizations — MICH‑05
Getting worse

Suggested Citation

1.

U.S. Preventive Services Task Force. (2014). Low-Dose Aspirin Use for the Prevention of Morbidity and Mortality From Preeclampsia: Preventive Medication. Retrieved from https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication